कृपया अन्य खोज का प्रयास करें
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms. The company develops AVA6000, FAPa-activated doxorubicin that is in Phase I clinical trial for treating locally advanced or metastatic-selected solid tumors; AVA3996, a tumor-targeted proteasome inhibitor based on bortezomib; AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing LR19128 PD-L1 XT; and collaboration and license agreement with Avacta and Daewoong Pharmaceutical Co. Ltd. for developing AFX-001 for solid organ transplant and graft vs host Disease, and AFX-002 for multiple sclerosis. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Tony Gardiner | 50 | 2016 | CFO, Company Secretary & Executive Director |
Eliot Richard Forster | 56 | 2018 | Independent Non-Executive Chairman |
Trevor J. Nicholls | 66 | 2013 | Independent Non-Executive Director |
Mark A. Goldberg | 69 | 2021 | Independent Non-Executive Director |
Krishna Komanduri | - | 2021 | Member of Scientific Advisory Board |
Stephane Champiat | - | 2021 | Member of Scientific Advisory Board |
Shaun Edward Chilton | 55 | 2023 | Non-Executive Director |
Paul Andrew Fry | 56 | 2020 | Independent Non-Executive Director |
James Spicer | - | 2021 | Member of Scientific Advisory Board |
Christina Marie Coughlin | 54 | 2022 | Head of Research & Development, Interim Chief Medical Officer and Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है